Article info

PDF
Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia

Authors

  1. Correspondence to Associate Professor Rachael L Morton, NHMRC Clinical Trials Centre, Camperdown, NSW 2050, Australia; rachael.morton{at}ctc.usyd.edu.au
View Full Text

Citation

Morton RL, Thompson JF
Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia

Publication history

  • Received December 6, 2018
  • Accepted December 9, 2018
  • First published January 3, 2019.
Online issue publication 
February 19, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.